FDA
approval
· 2023-03-03
FDA Approved: LEVETIRACETAM IN SODIUM CHLORIDE — Supplemental Application (Nexus Pharmaceuticals LLC)
Summary
FDA approved a supplemental application for levetiracetam in sodium chloride from Nexus Pharmaceuticals LLC to market a generic injectable formulation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVETIRACETAM IN SODIUM CHLORIDE (LEVETIRACETAM)